Ochsner Medical Center

About: Ochsner Medical Center is a healthcare organization based out in New Orleans, Louisiana, United States. It is known for research contribution in the topics: Population & Heart failure. The organization has 980 authors who have published 1159 publications receiving 49961 citations. The organization is also known as: Ochsner Hospital & Ochsner Foundation Hospital.

Assessment of the Quality of Working Life of Nurses: Care for the Caregiver Supportive Strategies

Abstract: Summary: In 2017, the nursing leadership of a large healthcare system launched a Care for the Caregiver initiative founded on the American Association of Critical-Care Nurses Healthy Work Environment Standards. The purpose of this program was to implement strategies to promote the nurses’ well-being and a higher quality of working life. Content Outline:

Giant Vascular Malformation With Thrombocytopenia in a Newborn

Abstract: A female infant was transferred to the neonatal intensive care unit from the neonatal nursery for evaluation on the day of delivery. She was the product of an elective cesarean section at 39 weeks gestation following a pregnancy complicated by maternal anemia, persistent left ovarian cyst, and obesity. She was large for gestational age (4095 g) with APGAR scores of 8 and 9 at 1 and 5 minutes, respectively. Routine prenatal ultrasonography had not revealed any abnormality but the infant was noted to have a large vascular malformation covering the entire right upper extremity (Figure 1), extending from the supraclavicular area to the fingertips. The lesion was deep purple in color with scattered petechiae. The infant was noted to hold the arm in a tightly flexed position. The infant’s hand circumference measured 15.9 cm, the forearm at the elbow crease measured 16.8 cm, and the proximal upper arm measured 15.2 cm. Laboratory values at birth were as follows:

Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis.

Abstract: Aims To assess the effect of duration of hyperglycaemia before basal insulin (BI) initiation on clinical outcomes in type 2 diabetes (T2D). Materials and methods Patients with T2D who initiated BI during 2009-2013, had continuous enrolment for ≥2 years preceding and ≥1 year following BI initiation ("index date"), and had ≥1 glycated haemoglobin (A1C) measure not at target (ie, ≥7.0%) within 6 months preindex date were included in the study. Patients were stratified by preindex-date duration of A1C ≥7.0%. Longitudinal A1C, weight, BMI, and diabetes medication were compared between cohorts for up to 15-month follow-up. Results Of 37 053 patients who initiated BI, 40.7%, 15.3%, 16.0%, and 28.0%, respectively, had uncontrolled A1C for <6, 6-<12, 12-<18 and 18-24 months preindex date. Baseline characteristics were similar between cohorts. Baseline A1C values were similar across cohorts (9.2%-9.6%). Mean follow-up A1C values were higher with longer preindex-date duration of uncontrolled A1C (8.0 ± 1.7%, 8.2 ± 1.6%, 8.5 ± 1.7%, and 8.6 ± 1.7% for <6, 6-<12, 12-<18, and 18-24 months); attainment of A1C <7.0% worsened with increasing preindex-date duration of A1C ≥7.0% (29.6%, 20.0%, 14.6%, and 11.5% for <6, 6-<12, 12-<18, and 18-24 months). Conclusions These data suggest that longer duration of uncontrolled A1C before BI initiation increases the risk of not reaching glycaemic targets. However, target attainment was poor in all cohorts, highlighting inadequate glycaemic control as an important unmet need in US patients with T2D.